|
[1]
|
中国心衰中心联盟, 苏州工业园区心血管健康研究院, 中国心血管健康联盟. 中国心衰中心工作报告(2021)——心力衰竭患者的诊疗现况[J]. 中国介入心脏病学杂志, 2022, 30(5): 328-336.
|
|
[2]
|
Boughorbel, S., et al. (2022) Applications of Machine Learning for Predicting Heart Failure. In: Sadasivuni, K.K., Ouakad, H.M., Al-Maadeed, S., Yalcin, H.C. and Bahadur, I.B., Eds., Predicting Heart Failure: Invasive, Non‐Invasive, Machine Learning and Artificial Intelligence Based Methods, Wiley, 171-188.
|
|
[3]
|
蔡佳音, 陈海涛, 王增武. 基于机器学习算法的心力衰竭10年患病风险可解释预测建模分析[J]. 中国心血管病研究, 2024, 22(4): 323-330.
|
|
[4]
|
Tohyama, T., Ide, T., Ikeda, M., Kaku, H., Enzan, N., Matsushima, S., et al. (2021) Machine Learning‐Based Model for Predicting 1 Year Mortality of Hospitalized Patients with Heart Failure. ESC Heart Failure, 8, 4077-4085. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Wang, H., Chai, K., Du, M., Wang, S., Cai, J., Li, Y., et al. (2021) Prevalence and Incidence of Heart Failure among Urban Patients in China: A National Population-Based Analysis. Circulation: Heart Failure, 14, e008406. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
孙桂锋, 刘宇, 李艳, 等. 基层医院慢性心力衰竭治疗现状调查[J]. 中国全科医学, 2018, 21(11): 1280-1284.
|
|
[7]
|
张毅, 魏海涛, 李竹琴. 治疗心力衰竭创新药物-沙库巴曲缬沙坦的客观性分析[J]. 中国循证心血管医学杂志, 2019, 11(0): 636-637, 640.
|
|
[8]
|
Gan, H., Tang, H., Huang, Y., Wang, D., Pu, P. and Zuo, Z. (2021) The ‘Diamond’ Approach to Personalized Drug Treatment of Heart Failure with Reduced Ejection Fraction. Reviews in Cardiovascular Medicine, 22, 573-584. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Ding, J., Tian, G. and Yuen, K.C. (2015) A New MM Algorithm for Constrained Estimation in the Proportional Hazards Model. Computational Statistics & Data Analysis, 84, 135-151. [Google Scholar] [CrossRef]
|
|
[10]
|
Huang, X., Xu, J. and Tian, G. (2019) On Profile mm Algorithms for Gamma Frailty Survival Models. Statistica Sinica, 29, 895-916. [Google Scholar] [CrossRef]
|
|
[11]
|
Zhang, C. (2010) Nearly Unbiased Variable Selection under Minimax Concave Penalty. The Annals of Statistics, 38, 894-942. [Google Scholar] [CrossRef]
|
|
[12]
|
Fan, J. and Li, R. (2001) Variable Selection via Nonconcave Penalized Likelihood and Its Oracle Properties. Journal of the American Statistical Association, 96, 1348-1360. [Google Scholar] [CrossRef]
|
|
[13]
|
Schwarz, G. (1978) Estimating the Dimension of a Model. The Annals of Statistics, 6, 461-464. [Google Scholar] [CrossRef]
|
|
[14]
|
戚德虎, 康继昌. BP神经网络的设计[J]. 计算机工程与设计, 1988(2): 47-49.
|
|
[15]
|
丁世飞, 齐丙娟, 谭红艳. 支持向量机理论与算法研究综述[J]. 电子科技大学学报, 2011, 40(1): 2-10.
|
|
[16]
|
Ahmad, T., Munir, A., Bhatti, S.H., Aftab, M. and Raza, M.A. (2017) Survival Analysis of Heart Failure Patients: A Case Study. PLOS ONE, 12, e0181001. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Markham, A. and Duggan, S. (2021) Vericiguat: First Approval. Drugs, 81, 721-726. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Armstrong, P.W., Pieske, B., Anstrom, K.J., Ezekowitz, J., Hernandez, A.F., Butler, J., et al. (2020) Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine, 382, 1883-1893. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
McMurray, J.J.V., et al. (2019) Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. New England Journal of Medicine, 381, 1995-2008.
|
|
[20]
|
Yao, Y., Zhang, R., An, T., Zhao, X. and Zhang, J. (2020) Cost‐Effectiveness of Adding Dapagliflozin to Standard Treatment for Heart Failure with Reduced Ejection Fraction Patients in China. ESC Heart Failure, 7, 3582-3592. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
黎风, 何梅, 母立峰, 等. 维立西呱治疗射血分数降低的心力衰竭的药物经济学研究[J]. 中国药房, 2023, 34(15): 1869-1873.
|
|
[22]
|
国家卫生健康委员会. 中国卫生健康统计年鉴: 2021 [M]. 北京: 中国协和医科大学出版社, 2021: 128.
|
|
[23]
|
Huang, J., Yin, H., Zhang, M., Ni, Q. and Xuan, J. (2017) Understanding the Economic Burden of Heart Failure in China: Impact on Disease Management and Resource Utilization. Journal of Medical Economics, 20, 549-553. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Hong, S., Lee, J., Park, S., Nam, J.H., Song, H.J., Park, S., et al. (2018) The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea. Clinical Drug Investigation, 38, 727-736. [Google Scholar] [CrossRef] [PubMed]
|